Výskum sa zameriava na mapovanie cis-regulačných komponentov v ľudských neurónoch, ktoré môžu byť spojené s dedičnosťou psychiatrických porúch.
Model kmeňových buniek Mount Sinai môže objasniť komplexnú biológiu niektorých psychiatrických porúch.
Výskumníci mapujú rizikové varianty ochorenia v ľudských neurónoch Icahn School of Medicine na Mount Sinai Použil sa jedinečný model kmeňových buniek. Táto práca môže pomôcť objasniť biologické mechanizmy za neuropsychiatrickými ochoreniami, ako je autizmus a schizofrénia.
Nan Yang, Ph.D., odborný asistent neurovedy. kredit: Mount Sinai Health System
In vitro bunkový model skupiny, ktorý bol nedávno publikovaný v časopise Cell Reports, bol navrhnutý tak, aby budúcim výskumníkom uľahčil pochopenie mechanizmov chorôb zahŕňajúcich celogenómové asociačné štúdie (GWAS), ktoré študujú rôzne choroby. Rizikové alely (odkazujú na bežné genetické varianty ohrozené) pre duševné poruchy. Táto štúdia by mohla pomôcť vyvinúť lepšie diagnostické metódy na odhaľovanie duševných problémov roky predtým, ako sa objavia symptómy pacienta.
Výskum sa zameral na identifikáciu cis-regulačných prvkov v ľudských neurónoch, ktoré môžu súvisieť s dedičnosťou psychiatrických porúch. Cis-regulačné prvky, vrátane zosilňovačov a promótorov, sú nekódujúce[{“ attribute=““>DNA regions that control the expression of genes and are essential parts of the genetic regulatory network. A considerable enrichment of common variants in the cis-regulatory elements, including those linked to bipolar disorder, schizophrenia, and autism spectrum disorder, has been found in previous genetic investigations.
“While common risk variants can shed light on the underlying molecular mechanism, identifying causal variants remains challenging for scientists,” says Nan Yang, Ph.D., Assistant Professor of Neuroscience at the Icahn School of Medicine of Mount Sinai, and senior author of the study. “That’s because cis-regulatory elements, particularly the enhancers, vary across cell types and activity states. Typically, researchers can only use postmortem brain samples where the neurons are no longer active. As a result, they are likely to miss enhancers that only respond to stimulation. Our approach is to map cis-regulatory elements in human neurons derived from pluripotent stem cells. That allows us to replicate neurons in the human brain that can be affected by different types of neuropsychiatric disease, and conduct mechanistic studies of human genetic variants that are inaccessible from other types of human samples.”
In recent years, GWAS have identified hundreds of gene regions associated with psychiatric disease, though understanding disease pathophysiology has been elusive. The functional genomics approach Dr. Yang and her team developed uses stem cell models that can help resolve the impact of patient-specific variants across cell types, genetic backgrounds, and environmental conditions. This unique approach effectively lays a foundation to translate risk variants to genes, genes to pathways, and pathways to circuits that reveal the synergistic relationship between disease risk factors within and between the cell types in the brain.
“Our research attempts to decode and transfer highly complex genetic insights into medically actionable information,” says Dr. Yang, who is a member of the Black Family Stem Cell Institute, The Friedman Brain Institute, and The Ronald M. Loeb Center for Alzheimer’s Disease within the Mount Sinai Health System. “That means improving our diagnostic capabilities, predicting clinical trajectories, and identifying presymptomatic points of therapeutic intervention for psychiatric disorders.”
By characterizing cell-type specific and activity-regulated gene expression patterns in human cell-derived neurons, Dr. Yang believes her team’s study can greatly benefit the research community. “Our data can guide choosing relevant cell types of experimental conditions to further elucidate molecular mechanisms of disease across the genome,” she points out. “And that could lead to the development of biomarkers that might detect neuropsychiatric disorders years before they manifest themselves in patients, while there is still time to delay or possibly prevent them.”
Reference: “Mapping cis-regulatory elements in human neurons links psychiatric disease heritability and activity-regulated transcriptional programs” by Carlos Sanchez-Priego, Ruiqi Hu, Linda L. Boshans, Matthew Lalli, Justyna A. Janas, Sarah E. Williams, Zhiqiang Dong and Nan Yang, 31 May 2022, Cell Reports.
DOI: 10.1016/j.celrep.2022.110877
